Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Xi Liu, Lei Chen & Tao Wang. (2023) Overcoming cisplatin resistance of human lung cancer by sinomenine through targeting the miR-200a-3p-GLS axis. Journal of Chemotherapy 35:4, pages 357-366.
Read now
Read now
Xiao-Mei Li, Mao-Ting Li, Ni Jiang, Ya-Chen Si, Meng-Mei Zhu, Qiao-Yuan Wu, Dong-Chen Shi, Hui Shi, Qing Luo & Bing Yu. (2021) Network Pharmacology-Based Approach to Investigate the Molecular Targets of Sinomenine for Treating Breast Cancer. Cancer Management and Research 13, pages 1189-1204.
Read now
Read now
Fucheng Zhao, Zhenxia Zhao, Yanru Han, Sujuan Li, Caili Liu & Kui Jia. (2021) Baicalin suppresses lung cancer growth phenotypes via miR-340-5p/NET1 axis. Bioengineered 12:1, pages 1699-1707.
Read now
Read now
Wenbin Liu, Xinfang Yu, Li Zhou, Jigang Li, Ming Li, Wei Li & Feng Gao. (2020) Sinomenine Inhibits Non-Small Cell Lung Cancer via Downregulation of Hexokinases II-Mediated Aerobic Glycolysis. OncoTargets and Therapy 13, pages 3209-3221.
Read now
Read now
Articles from other publishers (18)
Jingwei Yan, Jingqing Yang, Huifen Shen, Rong Gao & Shilong Lv. (2023)
Sinomenine regulates
circTRPM7
‐related pathway to inhibit gastric cancer cell growth and metastasis
. Chemical Biology & Drug Design 102:4, pages 870-881.
Crossref
Crossref
Subhadip Ghatak, Savita Khanna, Sashwati Roy, Mahesh Thirunavukkarasu, Seetur R. Pradeep, Brian C. Wulff, Mohamed S. El Masry, Anu Sharma, Ravichand Palakurti, Nandini Ghosh, Yi Xuan, Traci A. Wilgus, Nilanjana Maulik, Mervin C. Yoder & Chandan K. Sen. (2023) Driving adult tissue repair via re-engagement of a pathway required for fetal healing. Molecular Therapy 31:2, pages 454-470.
Crossref
Crossref
Prarthana Chatterjee, Suchetana Gupta & Satarupa Banerjee. 2023. Recent Frontiers of Phytochemicals. Recent Frontiers of Phytochemicals
261
293
.
Zuchang Zhu, Huixian Zhou, Fenglian Chen, Jianxiong Deng, Lina Yin, Baoen He, Qingzhong Hu & Tao Wang. (2022)
Sinomenine Derivatives: Synthesis, Antitumor Activity, and Apoptotic Induction in MCF‐7 Cells
via
IL‐6/PI3K/Akt/NF‐κB Signaling Pathway
. ChemMedChem 17:14.
Crossref
Crossref
Qian Cai, Hsin-Sheng Yang, Yi-Chen Li & Jiang Zhu. (2022) Dissecting the Roles of PDCD4 in Breast Cancer. Frontiers in Oncology 12.
Crossref
Crossref
Xiaomei Li, Wei Chen, Linxi Huang, Mengmei Zhu, Hongxia Zhang, Yachen Si, Hengyu Li, Qing Luo & Bing Yu. (2022) Sinomenine hydrochloride suppresses the stemness of breast cancer stem cells by inhibiting Wnt signaling pathway through down-regulation of WNT10B. Pharmacological Research 179, pages 106222.
Crossref
Crossref
Dongsheng Zhu, Xiangfei Xu, Ming Zhang & Tong Wang. (2022) TPX2 regulated by miR‑29c‑3p induces cell proliferation in osteosarcoma via the AKT signaling pathway. Oncology Letters 23:5.
Crossref
Crossref
Alexandru A. Sabo, Maria Dudau, George L. Constantin, Tudor C. Pop, Christoph-M. Geilfus, Alessio Naccarati & Mihnea P. Dragomir. (2021) Two Worlds Colliding: The Interplay Between Natural Compounds and Non-Coding Transcripts in Cancer Therapy. Frontiers in Pharmacology 12.
Crossref
Crossref
Wei Yang, Qihua Feng, Minjing Li, Jiaqi Su, Peiyuan Wang, Xu Wang, Yancun Yin, Xia Wang & Mingdong Zhao. (2021) Sinomenine Suppresses Development of Hepatocellular Carcinoma Cells via Inhibiting MARCH1 and AMPK/STAT3 Signaling Pathway. Frontiers in Molecular Biosciences 8.
Crossref
Crossref
Changle Ji, Jiashu Hu, Xuehui Wang, Wenfang Zheng, Xiaochong Deng, Hongming Song, Yunhe Yu, Qifeng Luo, Kaiyao Hua, Xiqian Zhou & Lin Fang. (2021) Hsa_circ_0053063 inhibits breast cancer cell proliferation via hsa_circ_0053063/hsa-miR-330-3p/PDCD4 axis. Aging 13:7, pages 9627-9645.
Crossref
Crossref
Li-Bo Tang, Shu-Xin Ma, Zhuo-Hui Chen, Qi-Yuan Huang, Long-Yuan Wu, Yi Wang, Rui-Chen Zhao & Li-Xia Xiong. (2021) Exosomal microRNAs: Pleiotropic Impacts on Breast Cancer Metastasis and Their Clinical Perspectives. Biology 10:4, pages 307.
Crossref
Crossref
Xin Chen, Duanxiu Li, Hailu Zhang, Yanwen Duan & Yong Huang. (2021) Sinomenine-phenolic acid coamorphous drug systems: Solubilization, sustained release, and improved physical stability. International Journal of Pharmaceutics 598, pages 120389.
Crossref
Crossref
Songwei Feng, Shanhui Luo, Chenchen Ji & Jia Shi. (2020) miR-29c-3p regulates proliferation and migration in ovarian cancer by targeting KIF4A. World Journal of Surgical Oncology 18:1.
Crossref
Crossref
Kaikai Lu, Qian Chen, Mengda Li, Lei He, Farooq Riaz, Tianyun Zhang & Dongmin Li. (2020) Programmed cell death factor 4 (PDCD4), a novel therapy target for metabolic diseases besides cancer. Free Radical Biology and Medicine 159, pages 150-163.
Crossref
Crossref
Qian Zheng, Qin Zhu, Cuiping Li, Shuang Hao, Jianguo Li, Xin Yu, Dengmei Qi & Yu Pan. (2020) Sinomenine Can Inhibit the Growth and Invasion Ability of Retinoblastoma Cell through Regulating PI3K/AKT Signaling Pathway. Biological and Pharmaceutical Bulletin 43:10, pages 1551-1555.
Crossref
Crossref
Yuming Wang, Guanning Shang, Wei Wang, Enduo Qiu, Yi Pei & Xiaojing Zhang. (2020) Magnoflorine inhibits the malignant phenotypes and increases cisplatin sensitivity of osteosarcoma cells via regulating miR-410-3p/HMGB1/NF-κB pathway. Life Sciences 256, pages 117967.
Crossref
Crossref
Kun-Hung Shen, Jui-Hsiang Hung, Yi-Ching Liao, Shu-Ting Tsai, Ming-Jiuan Wu & Pin-Shern Chen. (2020) Sinomenine Inhibits Migration and Invasion of Human Lung Cancer Cell through Downregulating Expression of miR-21 and MMPs. International Journal of Molecular Sciences 21:9, pages 3080.
Crossref
Crossref
Elizabeth Varghese, Alena Liskova, Peter Kubatka, Samson Mathews Samuel & Dietrich Büsselberg. (2020) Anti-Angiogenic Effects of Phytochemicals on miRNA Regulating Breast Cancer Progression. Biomolecules 10:2, pages 191.
Crossref
Crossref